Literature DB >> 11901049

Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray.

Claudio Napoli1, Filomena de Nigris, John S Welch, Federico B Calara, Robert O Stuart, Christopher K Glass, Wulf Palinski.   

Abstract

BACKGROUND: Maternal hypercholesterolemia during pregnancy is associated with markedly enhanced fatty streak formation in human fetal aortas and accelerated progression of atherosclerosis in normocholesterolemic children. METHODS AND
RESULTS: To establish the causal role of maternal hypercholesterolemia in a genetically homogeneous murine model and to test the hypothesis that pathogenic events during fetal development result in persistent changes in arterial gene expression, female LDL receptor-deficient (LDLR(-/-)) mice were fed regular chow or high-fat diets supplemented with 0.075% or 1.25% cholesterol during pregnancy. Lesion sizes were determined in the aortic origin of their chow-fed offspring at 3 months. Maternal hypercholesterolemia more than doubled lesion sizes in male offspring (P<0.0001 for the 0.0075% cholesterol group). Microarray analysis of the expression of 11 000 murine genes in the nonatherosclerotic descending aorta by Affymetrix gene chips suggested that 139 genes were significantly regulated in offspring of hypercholesterolemic mothers. A subset of 12 of the upregulated transcripts was subjected to secondary analysis by semiquantitative PCR of pooled RNA and 4 genes were found to be upregulated >1.7-fold. Quantitative PCR for one of these genes using RNA from individual mice yielded similar results. Comparative immunostaining for several of the above genes also indicated increased protein content in offspring of hypercholesterolemic mothers.
CONCLUSIONS: These findings establish an atherogenic effect of maternal hypercholesterolemia in genetically uniform mice and indicate that changes in aortic gene expression persist long after fetal exposure to hypercholesterolemia. In addition to elucidating pathogenic mechanisms initiated during fetal development, this approach may identify genes in morphologically normal arteries that influence the susceptibility to classical risk factors of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11901049     DOI: 10.1161/hc1102.106792

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  54 in total

1.  Association of Maternal Prepregnancy Dyslipidemia With Adult Offspring Dyslipidemia in Excess of Anthropometric, Lifestyle, and Genetic Factors in the Framingham Heart Study.

Authors:  Michael M Mendelson; Asya Lyass; Christopher J O'Donnell; Ralph B D'Agostino; Daniel Levy
Journal:  JAMA Cardiol       Date:  2016-04-01       Impact factor: 14.676

2.  l-Citrulline and l-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits.

Authors:  Toshio Hayashi; Packiasamy A R Juliet; Hisako Matsui-Hirai; Asaka Miyazaki; Akiko Fukatsu; Jun Funami; Akihisa Iguchi; Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-12       Impact factor: 11.205

Review 3.  Experimental models of developmental programming: consequences of exposure to an energy rich diet during development.

Authors:  James A Armitage; Paul D Taylor; Lucilla Poston
Journal:  J Physiol       Date:  2005-02-03       Impact factor: 5.182

4.  Developmental programming of sex-dependent alterations in lipid metabolism: a role for long-term, sex-specific alterations in LDL-receptor expression. Focus on "developmental programming of lipid metabolism and aortic vascular function in C57BL/6 mice: a novel study suggesting an involvement of LDL-receptor".

Authors:  Barbara T Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

Review 5.  Metabolic syndrome: from epidemiology to systems biology.

Authors:  Aldons J Lusis; Alan D Attie; Karen Reue
Journal:  Nat Rev Genet       Date:  2008-11       Impact factor: 53.242

6.  Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet.

Authors:  Claudio Napoli; Ines Martin-Padura; Filomena de Nigris; Marco Giorgio; Gelsomina Mansueto; Pasquale Somma; Mario Condorelli; Giacomo Sica; Gaetano De Rosa; PierGiuseppe Pelicci
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

7.  Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice.

Authors:  Claudio Napoli; Eric Ackah; Filomena De Nigris; Piero Del Soldato; Francesco P D'Armiento; Ettore Crimi; Mario Condorelli; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

8.  Perinatal tobacco smoke exposure increases vascular oxidative stress and mitochondrial damage in non-human primates.

Authors:  David G Westbrook; Peter G Anderson; Kent E Pinkerton; Scott W Ballinger
Journal:  Cardiovasc Toxicol       Date:  2010-09       Impact factor: 3.231

9.  Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21.

Authors:  Valerio Costa; Claudia Angelini; Luciana D'Apice; Margherita Mutarelli; Amelia Casamassimi; Linda Sommese; Maria Assunta Gallo; Marianna Aprile; Roberta Esposito; Luigi Leone; Aldo Donizetti; Stefania Crispi; Monica Rienzo; Berardo Sarubbi; Raffaele Calabrò; Marco Picardi; Paola Salvatore; Teresa Infante; Piergiuseppe De Berardinis; Claudio Napoli; Alfredo Ciccodicola
Journal:  PLoS One       Date:  2011-04-20       Impact factor: 3.240

10.  Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment.

Authors:  Shaghayegh Haghjooy Javanmard; Mehdi Nematbakhsh; Mohammad Hosein Sanei
Journal:  Nutr Metab (Lond)       Date:  2009-03-24       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.